✦ LIBER ✦

Is dedifferentiated chondrosarcoma a ?de-differentiated? chondrosarcoma?

✍ Scribed by Aigner, T.; Unni, K. K.

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 72 KB
Volume: 189
Category: Article
ISSN: 0022-3417
DOI: 10.1002/(sici)1096-9896(199912)189:4<445::aid-path468>3.0.co;2-m

No coin nor oath required. For personal study only.

✦ Synopsis

Since its first description 30 years ago, dedifferentiated chondrosarcoma has been the prototype of all dedifferentiated sarcomas. The presence of two tumour portions of different mesenchymal differentiation lineages in these neoplasms gives rise to three key questions, which are on the way to being resolved. Does it split up? And if so, how does it split up and when does it split up? Accumulating data provide evidence for a common monoclonal origin of both tumour portions and suggest that dedifferentiated chondrosarcoma is a paradigmatic neoplasm of mesenchymal transdifferentiaton in vivo. Two categories emerge of dedifferentiated chondrosarcomas with different cell biology: the classical one, with a low-grade chondroid component splitting up late, and a second type, with a high-grade chondroid component splitting up early in tumour development.

📜 SIMILAR VOLUMES

Molecular genetic characterization of bo

Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis

✍ Bov�e, Judith V. M. G.; Cleton-Jansen, Anne-Marie; Rosenberg, Carla; Taminiau, A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 1 views

Dedifferentiated chondrosarcoma is defined as a high-grade, anaplastic sarcoma adjacent to a low-grade malignant cartilage-forming tumour. Controversy remains as to whether the anaplastic and cartilaginous components are derived from a common precursor cell, or whether they represent separate genoty

Altered p53 is associated with aggressiv

Altered p53 is associated with aggressive behavior of chondrosarcoma : A long term follow-up study

✍ Yumi Oshiro; Vijaya Chaturvedi; Dorothy Hayden; Tipu Nazeer; Mark Johnson; Denni 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

BACKGROUND. p53 is a major tumor suppressor gene that has been implicated in the biology of a variety of human neoplasms, including some that affect the skeleton. Recent studies based on small numbers of cases have shown that overexpression or alteration of the p53 gene is frequently present in high

Overexpression of cathepsin B and urokin

Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma

✍ Carsten G. Häckel; Sabine Krueger; Hans-Jürgen Grote; Yumi Oshiro; Sherie Hodges 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 2 views